Linda Wrijil

ORCID: 0000-0003-0786-8390
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Cutaneous lymphoproliferative disorders research
  • Veterinary Oncology Research
  • Cell Adhesion Molecules Research
  • Skin and Cellular Biology Research
  • COVID-19 and healthcare impacts
  • SARS-CoV-2 detection and testing
  • T-cell and B-cell Immunology
  • Autopsy Techniques and Outcomes
  • Climate Change and Health Impacts
  • Immunotherapy and Immune Responses
  • Infectious Diseases and Mycology
  • Dermatological and COVID-19 studies
  • Autoimmune Bullous Skin Diseases

New England Disabled Sports
2023-2025

Tufts University
2020-2022

An understanding of protective immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for vaccine and public health strategies aimed at ending the global disease 2019 (COVID-19) pandemic. A key unanswered question whether infection with SARS-CoV-2 results in against reexposure. We developed a rhesus macaque model observed that macaques had high viral loads upper lower tract, humoral cellular immune responses, pathologic evidence pneumonia. After initial...

10.1126/science.abc4776 article EN cc-by Science 2020-05-20

Abstract Coronavirus disease 2019 (COVID-19) in humans is often a clinically mild illness, but some individuals develop severe pneumonia, respiratory failure and death 1–4 . Studies of acute syndrome coronavirus 2 (SARS-CoV-2) infection hamsters 5–7 nonhuman primates 8–10 have generally reported clinical disease, preclinical SARS-CoV-2 vaccine studies demonstrated reduction viral replication the upper lower tracts 11–13 Here we show that high-dose intranasal results including high levels...

10.1038/s41591-020-1070-6 article EN cc-by Nature Medicine 2020-09-03

To determine the feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patients. 60 patients who expired between 04/22/2020–05/06/2020 due to were considered for inclusion study, based on availability study staff. Minimally was performed with 14G core biopsies through a 13G coaxial needle. The protocol required 20 cores liver, 30 lung, 12 spleen, heart, kidney, 4 breast, testis, 2 skeletal muscle, fat total 112 per patient. Quality samples evaluated by number,...

10.1007/s00261-020-02753-7 article EN other-oa Abdominal Radiology 2020-09-17

Cytotoxic interface dermatitis (CID) is a pattern reaction predominantly at the dermo-epidermal junction that encapsulates numerous chronic non-communicable inflammatory skin conditions in which basal keratinocytes are attacked by T-cell infiltrate leading to apoptosis, lymphocytic satellitosis and vacuolar degeneration. Though many diseases include CID, type of clinical presentation tissue patterns expressed from disease varies. In this study, we evaluate commonalities discrepancies...

10.3389/fvets.2024.1471590 article EN cc-by Frontiers in Veterinary Science 2025-01-22

Autoimmune skin diseases are complex and thought to arise from a combination of genetics environmental exposures, which trigger an ongoing immune response against self-antigens. Companion animals including cats dogs known develop inflammatory conditions similar humans share the same environment, providing opportunities study spontaneous disease that encompasses genetic factors with One Health approach. A strength comparative immunology approaches is profiles may be assessed across different...

10.1016/j.crimmu.2021.03.003 article EN cc-by-nc-nd Current Research in Immunology 2021-01-01

Cutaneous T-cell lymphoma (CTCL) is an uncommon type of involving malignant skin-resident or skin-homing T cells. Canine epitheliotropic (EL) the most common form CTCL in dogs, and it also spontaneously arises from lymphocytes mucosa skin. Clinically, can be difficult to distinguish early-stage CTCLs apart other forms benign interface dermatitis (ID) both dogs people. Our objective was identify novel biomarkers that EL ID, perform comparative transcriptomics human canine EL. Here, we present...

10.3389/fvets.2023.1225764 article EN cc-by Frontiers in Veterinary Science 2023-11-03

There is a need to standardize pathologic endpoints in animal models of SARS-CoV-2 infection help benchmark study quality, improve cross-institutional comparison data, and assess therapeutic efficacy so that potential drugs vaccines for can rapidly advance. The Syrian hamster model tractable small COVID-19 clinical disease humans. Using the model, authors used traditional assessment with quantitative image analysis outcomes hamsters administered polyclonal immune sera from previously...

10.1177/03009858221095794 article EN Veterinary Pathology 2022-05-06
Coming Soon ...